Superbug and viral pathogen treatment developer Recce Pharmacetical (ASX:RCE)’s unapproved drug R327 has successfully saved a patient suffering a life-threatening illness.
Despite not undertaking clinical trials, nasal treatment R327 was accessible to the individual via Category A of the Therapeutic Goods Administration special access scheme. Recce (ASX:RCE) intends to proceed with clinical trials for the product.
The news has shot Recce’s shares up 5.1 per cent to $1.03
Copyright 2021 – Finance News Network
18 Sep 2019 - Centuria Property Funds, as Responsible Entity for the Centuria Metropolitan REIT (ASX:CMA), is pleased to announce the acquisition of interests in two A-grade office properties in fringe CBD locations across Sydney and Perth for a total purchase price of $380.5 million.
19 Mar 2021 - Fortescue (ASX:FMG) and its subsidiaries launched a high yield bond offering of US$750 million of senior unsecured notes, which has today been upsized to $US1.5 billion as a result of strong demand.
03 Mar 2021 - St Barbara (ASX:SBM) advises that Macmahon Holdings has been appointed the underground mining contractor at the Gwalia mine at Leonora Operations in Western Australia.
18 May 2023 - A snapshot of the stocks on the move featuring Latin Resources (ASX:LRS), European Metals (ASX:EMH), Golden Mile Resources (ASX:G88) and Immutep (ASX:IMM).
19 Mar 2020 - Qantas (ASX:QAN) and Jetstar are to suspend scheduled international flights from late March, following latest government travel advice regarding the coronavirus with some ongoing ad hoc services possible.
22 Jan 2020 - Advanced materials company, First Graphene (ASX:FGR) has signed a supply agreement with Footwear Industries, trading as “Steel Blue, for the exclusive supply of PureGRAPH®10 for a twenty-four month term.
17 Nov 2020 - Afterpay Limited (ASX:APT) today announced the appointment of Nick Molnar as co-CEO and Managing Director, sharing the role with current CEO and Managing Director, Anthony Eisen.
